First published online 26 September 2006
doi: 10.1242/jcs.03186
Journal of Cell Science 119, 4315-4321 (2006)
Published by The Company of Biologists 2006
Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis
Christina Karamboulas1,2,
Gabriel D. Dakubo3,
Jun Liu1,
Yves De Repentigny3,
Katherine Yutzey4,
Valerie A. Wallace3,
Rashmi Kothary3 and
Ilona S. Skerjanc1,2,*
1 Department of Biochemistry, Medical Sciences Building, University of Western Ontario, London, Ontario, N6A 5C1, Canada
2 Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, K1H 8M5, Canada
3 Molecular Medicine Program, Ottawa Health Research Institute, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada
4 Division of Molecular Cardiovascular Biology, Cincinnati Children's Medical Center ML7020, Cincinnati, OH, USA

View larger version (59K):
[in a new window]
|
Fig. 1. (A-D) The expression of MEF2C/EnR in cardiomyoblasts inhibits the development of cardiac muscle. P19(Nkx-MEF2C/EnR) cells (C,D) and P19(control) cells (A,B) were aggregated with DMSO and fixed for immunofluorescence on day 6 of differentiation to examine the presence of cardiac muscle. Cells were stained with the anti-MyHC antibody MF20 (B,D), and nuclei were counter-stained with Hoechst dye 33258 (A,C) (Magnification 400x).
|
|

View larger version (42K):
[in a new window]
|
Fig. 2. MEF2C/EnR expression in cardiomyoblasts initially enhances Nkx2-5 and MEF2C transcript levels and subsequently downregulates cardiac -actin, Gata4, Bmp4, Nkx2-5 and Mef2c transcripts. (A-J) P19(Nkx-MEF2C/EnR) and P19(control) cells were differentiated in the presence of DMSO. 12 µg of total RNA that was harvested on days 0, 2, 3, 4 and 6 were northern blotted and probed as indicated (A-E). Nkx2-5, MEF2C/EnR, Mef2c, and ß-actin expression were detected using RT-PCR (G-I). A 750 bp EcoRI fragment of rabbit 18S cDNA (F) or a 520 bp PCR product of mouse ß-actin (J) were used as loading standards.
|
|

View larger version (106K):
[in a new window]
|
Fig. 3. MEF2C/EnR expressed via an Nkx2-5 enhancer abrogated heart muscle development in type-I transgenic mouse embryos. Wild-type (A,D,G,J), type-I (B,E,H,K) and type-II (C,F,I,L) embryos were harvested on E9.5 and photographed under a dissecting microscope (A-C). The heart area is indicated by a circle. Cryosections were prepared and in situ hybridization was performed with probes against Nkx2-5 (D-F), cardiac -actin (G-I), and Gata4 (J-L). The heart region (arrowhead) and head (h) are indicated.
|
|

View larger version (79K):
[in a new window]
|
Fig. 4. MEF2C/EnR expressed via an Nkx2-5 enhancer resulted in a thin-walled myocardium in type-II founder transgenic mouse embryos. Immunofluorescence was performed with anti-MyHC antibody MF20 (D,E,F) to indicate the cardiomyocytes in sections from wild-type (A,D), type-I (B,E) and type-II (C,F) transgenic embryos. Sections were stained with Hoechst dye 33258 to indicate nuclei (A-C).
|
|

View larger version (11K):
[in a new window]
|
Fig. 5. Mechanistic model for the effect of MEF2 disruption on the differentiation of cells into cardiac muscle. In the cardiomyoblast, MEF2C, GATA4 and Nkx2-5 are important for the maintenance of the cardiomyoblast phenotype and for subsequent differentiation into cardiomyocytes (Dodou et al., 2004 ; Grepin et al., 1997 ; Jamali et al., 2001 ; Reecy et al., 1999 ; Searcy et al., 1998 ; Skerjanc et al., 1998 ). The presence of MEF2C/EnR downregulated the expression of genes encoding Nkx2-5, MEF2C and GATA4, and inhibited the progression of cardiomyoblasts into cardiomyocytes. An initial enhancement of Nkx2-5 and MEF2C in the stem/mesoderm cell confirmed previous results showing an increase in Nkx2-5 and Gata4 expression, probably due to the relief of HDAC inhibition of cardiomyoblast formation by MEF2C/EnR (Karamboulas et al., 2006 ).
|
|
© The Company of Biologists Ltd 2006